Research & Development: Page 88

PharmaVoice Team/PharmaVoice

Improving Clinical-Trial Performance

The Clinical-Trial Process Improving Clinical-Trial Performance Effectively managing the vast number of dispersed resources involved in conducting a clinical trial requires a cohesive approach that assures clinical study and regulatory knowledge to achieve hig...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Clinical Document Development: Planning for Accelerated Timelines

Jean Hosutt, Ph.D., Director, Medical Regulatory Writing Clinical Document Development: Planning for Accelerated Timelines clinical document development Active planning is required to facilitate the partnership between the sponsor and medical-writing contractor resultin...
By PharmaVoice Team • Jan. 2, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

Clinical Data Strategies for Performance Optimization

Octagon Research Solutions Inc. Data Standards Organizations that hesitate to embrace these standards as opportunities will be at a competitive disadvantage. They will continue to struggle with the tactical “cost” of transforming the ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

The Drug Information Association (DIA) will play host to the largest group of exhibitors and attendees in its 41-year history. More than 815 exhibit booths representing more than 550 companies will be in attendance at the Washington Convention Center in Washington, D.C., June 26-June 30, 2005, ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Letter from the Editor The Forum Clinical Services: Outsourcing: A Vital Clinical Strategy — A large, unmet need exists for improved research and development (R&D) productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and f...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Phase IV Juggernaut: Best Practices for Success

Dimensional HealthCare Inc. Late-stage success depends on an in-depth understanding of the Phase IV scientific drivers, the commercial objectives, and the integration of clinical and marketing knowledge. Adam Serody VP, Clinical Solutions The Phase IV Juggernaut: ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Translational Research: Making the Transition from R to D

Translational Research: Making the Transition from R to D There is a growing interest in translational research, which aims to bridge the gap between advances in basic research and the development of safe and effective therapies. June 2005 PharmaVOICE Despite increased investment in research and ...
By Denise Myshko • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Cover

Clinical-Trial Transparency: The Pros and Cons Representing Biotech with David King DTC: The Next Evolution PharmaVOICE www.pharmavoice.com June 2005 Volume 5, Number 6 Download PDF
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah L...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's New

New Healthcare-related Products, Services, and Companies PMI Appoints Task Force to Oversee CME Compliance Pri-Med Institute (PMI) has named a task force of medical and educational experts to ensure that all of its continuing medical education (CME) programs meet and exceed the new Standards of C...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's on Your Mind -- Opinions

Opinions What’s on your mind What have you heard lately? In the September issue of PharmaVOICE, we asked readers to relate the most surprising statistics or strange facts that they have come across. PharmaVOICE learned that every human spent about half an hour as a single cell and that 70% of con...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Letter from the Editor By Taren Grom Editor Driving business forward According to the U.S. Small Business Administration, more than 50% of small businesses fail in the first year and 95% fail within the first five years. Some entrepreneurs describe their decision to set up their own business as a...
By Taren Grom • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

On The Cover Flying high on a vision Even as pharmaceutical companies merge to form giant conglomerates, business leaders are choosing to step out on their own and are taking some calculated risks. They embrace the challenges that come with being an entrepreneur and strive to make a difference in...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

November 18-20, 2003, Westin Copley Place — Boston LogiPharma 2003 This is an opportunity for attendees to hear how competitors and peers are maximizing every facet of their supply-chain strategy. The event provides the opportunity to hear more than 25 confirmed case studies delivered by senior-l...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

November 2003E-media MDS Pharma Express is intuitive, user-friendly, and designed to operate with minimal computer requirements and the highest level of Internet security –providing easy access to current study status information in real time, anytime. MDS Electronic Data-Delivery System Allows f...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Creating a Guidance System for Life-Science Brands

Creating a Guidance System for Life-Science Brands While meaningful biomedical research depends on proteomics, genetics, and genomics tools, their ultimate application also will depend on successful commercialization and marketing tools. Mark Stinson President ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Recruitment: To Centralize or Decentralize? This is the Question.

Recruitment: To Centralize or Decentralize? This is the Question. Liz Moench President and CEO Patient and Investigator Recruitment In many people’s minds, centralized recruitment often symbolizes big money and big studies. But in actuality, nothing could...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Strategic Phase II Planning -- More Important Than Ever for the Biotech Industry

Strategic Phase II Planning — More Important Than Ever for the Biotech Industry Lukas Makris, Ph.D. CEO Phase II programs should not only be judged on how well the objectives were met, but on how well they might predict the Phase III outcome. The biotechnology industr...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

A Robust Future for Phase IV Trials

A Robust Future for Phase IV Trials May 2005 VIEW on Biotechnology Clinical Trials Dimensional HealthCare Inc., Cedar Knolls, N.J., designs, implements, and provides community-based research to the pharmaceutical and medical-device industries, focusing on the design and implementation of la...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Table of contents Letter from the Editor The Forum Biotech: The Perfect Storm — A relatively more favorable funding environment, cutting-edge technologies, and a strong position at the partnership table have many of today’s biotechnology companies in a position for success. Company Listing by Top...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's New

Society of Hospital Medicine Launches New Medical Journal The Society of Hospital Medicine plans to launch a new peer-reviewed medical journal, The Journal of Hospital Medicine, in 2006. The journal will promote the science and practice of hospital medicine and the enhancement of in-patient care....
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

Infotrieve Introduces New Search and Discovery Tool The LSRC employs a radically different approach to discovery, evolving the traditional use of content from a “find-and-review” approach to a unique “search-discover-and-create” approach capable of delivering dramatic improvements in research pro...
By PharmaVoice Team • Jan. 2, 2008